Kallikrein-related peptidases

Cellular and Molecular Life Sciences

Volumn 65, Issue 13, 2008, Pages 2019-2038

  Lundwall, A ^a   Brattsand, M ^b  

^a LUND UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Cancer; Desquamation; Evolution; Liquefaction; Prostate; Protease; Semen; Skin

Indexed keywords

KALLIKREIN; KALLIKREIN 1; KALLIKREIN 10; KALLIKREIN 11; KALLIKREIN 13; KALLIKREIN 2; KALLIKREIN 3; KALLIKREIN 4; KALLIKREIN 5; KALLIKREIN 6; KALLIKREIN 7; NEUROPSIN; PEPTIDASE; TUMOR MARKER;

AMINO ACID SEQUENCE; CELL MATURATION; CRYSTAL STRUCTURE; ENZYME ACTIVITY; GENE LOCUS; HOMEOSTASIS; HUMAN; KALLIKREIN KININ SYSTEM; LIQUEFACTION; NERVE CELL; NERVE CELL PLASTICITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REPRODUCTION; REVIEW; TOOTH DEVELOPMENT;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; DNA; EVOLUTION, MOLECULAR; FEMALE; HUMANS; KALLIKREIN-KININ SYSTEM; KALLIKREINS; MALE; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; PREGNANCY; RATS; SEMEN; SEQUENCE HOMOLOGY, AMINO ACID; SEQUENCE HOMOLOGY, NUCLEIC ACID; SKIN; TISSUE DISTRIBUTION; TUMOR MARKERS, BIOLOGICAL;

RATTUS;

EID: 46449093665     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-008-8024-3     Document Type: Review

References (171)

1. Kraut, H., Frey, E. K. and Werle, E. (1930) Der Nachweis eines Kreislaufhormons in der Pankreasdrüse. Hoppe-Seyler's Z. Physiol. Chem. 192, 1-21.
2. Mason, A. J., Evans, B. A., Cox, D. R., Shine, J. and Richards, R. I. (1983) Structure of mouse kallikrein gene family suggests a role in specific processing of biologically active peptides. Nature 303, 300-307.
3. Evans, B. A., Drinkwater, C. C. and Richards, R. I. (1987) Mouse glandular kallikrein genes. Structure and partial sequence analysis of the kallikrein gene locus. J. Biol. Chem. 262, 8027-8034.
4. Wines, D. R., Brady, J. M., Pritchett, D. B., Roberts, J. L. and MacDonald, R. J. (1989) Organization and expression of the rat kallikrein gene family. J. Biol. Chem. 264, 7653-7662.
5. Bothwell, M. A., Wilson, W. H. and Shooter, E. M. (1979) The relationship between glandular kallikrein and growth factor-processing proteases of mouse submaxillary gland. J. Biol. Chem. 254, 7287-7294.
6. Frey, P., Forand, R., Maciag, T. and Shooter, E. M. (1979) The biosynthetic precursor of epidermal growth factor and the mechanism of its processing. Proc. Natl. Acad. Sci. USA 76, 6294-6298.
7. Thomas, K. A., Baglan, N. C. and Bradshaw, R. A. (1981) The amino acid sequence of the gamma-subunit of mouse submaxillary gland 7 S nerve growth factor. J. Biol. Chem. 256, 9156-9166.
8. Fukushima, D., Kitamura, N. and Nakanishi, S. (1985) Nucleotide sequence of cloned cDNA for human pancreatic kallikrein. Biochemistry 24, 8037-8043.
9. Schedlich, L. J., Bennetts, B. H. and Morris, B. J. (1987) Primary structure of a human glandular kallikrein gene. DNA 6, 429-437.
10. Lundwall, A. and Lilja, H. (1987) Molecular cloning of human prostate specific antigen cDNA. FEBS Lett. 214, 317-322.
11. Gan, L., Lee, I., Smith, R., Argonza-Barrett, R., Lei, H., McCuaig, J., Moss, P., Paeper, B. and Wang, K. (2000) Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region. Gene 257, 119-130.
12. Harvey, T. J., Hooper, J. D., Myers, S. A., Stephenson, S. A., Ashworth, L. K. and Clements, J. A. (2000) Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4. J. Biol. Chem. 275, 37397-37406.
13. Yousef, G. M., Chang, A., Scorilas, A. and Diamandis, E. P. (2000) Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4. Biochem. Biophys. Res. Commun. 276, 125-133.
14. Lundwall, A., Band, V., Blaber, M., Clements, J. A., Courty, Y., Diamandis, E. P., Fritz, H., Lilja, H., Malm, J., Maltais, L. J., Yvonne Olsson, A., Petraki, C., Scorilas, A., Sotiropoulou, G., Stenman, U. H., Stephan, C., Talieri, M. and Yousef, G. M. (2006) A comprehensive nomenclature for serine proteases with homology to tissue kallikreins. Biol. Chem. 387, 637-641.
15. Lu, W., Zhou, D., Glusman, G., Utleg, A. G., White, J. T., Nelson, P. S., Vasicek, T. J., Hood, L. and Lin, B. (2006) KLK31P is a novel androgen regulated and transcribed pseudogene of kallikreins that is expressed at lower levels in prostate cancer cells than in normal prostate cells. Prostate 66, 936-944.
16. Yousef, G. M., Borgono, C. A., Michael, I. P. and Diamandis, E. P. (2004) Cloning of a kallikrein pseudogene. Clin. Biochem. 37, 961-967.
17. Bode, W. and Schwager, P. (1975) The refined crystal structure of bovine beta-trypsin at 1.8 Å resolution. II. Crystallographic refinement, calcium binding site, benzamidine binding site and active site at pH 7.0. J. Mol. Biol. 98, 693-717.
18. Bode, W., Chen, Z., Bartels, K., Kutzbach, C., Schmidt-Kastner, G. and Bartunik, H. (1983) Refined 2 Å X-ray crystal structure of porcine pancreatic kallikrein A, a specific trypsin-like serine proteinase. Crystallization, structure determination, crystallographic refinement, structure and its comparison with bovine trypsin. J. Mol. Biol. 164, 237-282.
19. Bourgeois, L., Brillard-Bourdet, M., Deperthes, D., Juliano, M. A., Juliano, L., Tremblay, R. R., Dube, J. Y. and Gauthier, F. (1997) Serpin-derived peptide substrates for investigating the substrate specificity of human tissue kallikreins hK1 and hK2. J. Biol. Chem. 272, 29590-29595.
20. 2+ and extracellular protease inhibitors. Eur. J. Biochem. 262, 781-789.
21. Matsumura, M., Bhatt, A. S., Andress, D., Clegg, N., Takayama, T. K., Craik, C. S. and Nelson, P. S. (2005) Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries. Prostate 62, 1-13.
22. Debela, M., Magdolen, V., Schechter, N., Valachova, M., Lottspeich, F., Craik, C. S., Choe, Y., Bode, W. and Goettig, P. (2006) Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences. J. Biol. Chem. 281, 25678-25688.
23. Borgono, C. A., Gavigan, J. A., Alves, J., Bowles, B., Harris, J. L., Sotiropoulou, G. and Diamandis, E. P. (2007) Defining the extended substrate specificity of kallikrein 1-related peptidases. Biol. Chem. 388, 1215-1225.
24. Brattsand, M. and Egelrud, T. (1999) Purification, molecular cloning, and expression of a human stratum corneum trypsin-like serine protease with possible function in desquamation. J. Biol. Chem. 274, 30033-30040.
25. Brattsand, M., Stefansson, K., Lundh, C., Haasum, Y. and Egelrud, T. (2005) A proteolytic cascade of kallikreins in the stratum corneum. J. Invest. Dermatol. 124, 198-203.
26. Michael, I. P., Sotiropoulou, G., Pampalakis, G., Magklara, A., Ghosh, M., Wasney, G. and Diamandis, E. P. (2005) Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression. J. Biol. Chem. 280, 14628-14635.
27. Bernett, M. J., Blaber, S. I., Scarisbrick, I. A., Dhanarajan, P., Thompson, S. M. and Blaber, M. (2002) Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system. J. Biol. Chem. 277, 24562-24570.
28. Blaber, S. I., Scarisbrick, I. A., Bernett, M. J., Dhanarajan, P., Seavy, M. A., Jin, Y., Schwartz, M. A., Rodriguez, M. and Blaber, M. (2002) Enzymatic properties of rat myelencephalon-specific protease. Biochemistry 41, 1165-1173.
29. Angelo, P. F., Lima, A. R., Alves, F. M., Blaber, S. I., Scarisbrick, I. A., Blaber, M., Juliano, L. and Juliano, M. A. (2006) Substrate specificity of human kallikrein 6: Salt and glycosaminoglycan activation effects. J. Biol. Chem. 281, 3116-3126.
30. Shimizu, C., Yoshida, S., Shibata, M., Kato, K., Momota, Y., Matsumoto, K., Shiosaka, T., Midorikawa, R., Kamachi, T., Kawabe, A. and Shiosaka, S. (1998) Characterization of recombinant and brain neuropsin, a plasticity-related serine protease. J. Biol. Chem. 273, 11189-11196.
31. Kishi, T., Cloutier, S. M., Kundig, C., Deperthes, D. and Diamandis, E. P. (2006) Activation and enzymatic characterization of recombinant human kallikrein 8. Biol. Chem. 387, 723-731.
32. Luo, L. Y., Shan, S. J., Elliott, M. B., Soosaipillai, A. and Diamandis, E. P. (2006) Purification and characterization of human kallikrein 11, a candidate prostate and ovarian cancer biomarker, from seminal plasma. Clin. Cancer Res. 12, 742-750.
33. Memari, N., Jiang, W., Diamandis, E. P. and Luo, L. Y. (2007) Enzymatic properties of human kallikrein-related peptidase 12 (KLK12). Biol. Chem. 388, 427-435.
34. Felber, L. M., Kundig, C., Borgono, C. A., Chagas, J. R., Tasinato, A., Jichlinski, P., Gygi, C. M., Leisinger, H. J., Diamandis, E. P., Deperthes, D. and Cloutier, S. M. (2006) Mutant recombinant serpins as highly specific inhibitors of human kallikrein 14. FEBS J. 273, 2505-2514.
35. Stefansson, K., Brattsand, M., Ny, A., Glas, B. and Egelrud, T. (2006) Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum. Biol. Chem. 387, 761-768.
36. Debela, M., Hess, P., Magdolen, V., Schechter, N. M., Steiner, T., Huber, R., Bode, W. and Goettig, P. (2007) Chymotryptic specificity determinants in the 1.0 A structure of the zinc-inhibited human tissue kallikrein 7. Proc. Natl. Acad. Sci. USA 104, 16086-16091.
37. Egelrud, T. and Lundstrom, A. (1991) A chymotrypsin-like proteinase that may be involved in desquamation in plantar stratum corneum. Arch. Dermatol. Res. 283, 108-112.
38. Malm, J., Hellman, J., Hogg, P. and Lilja, H. (2000) Enzymatic action of prostate-specific antigen (PSA or hK3): Substrate specificity and regulation by Zn(2+), a tight-binding inhibitor. Prostate 45, 132-139.
39. Robert, M., Gibbs, B. F., Jacobson, E. and Gagnon, C. (1997) Characterization of prostate-specific antigen proteolytic activity on its major physiological substrate, the sperm motility inhibitor precursor/semenogelin I. Biochemistry 36, 3811-3819.
40. Villoutreix, B. O., Getzoff, E. D. and Griffin, J. H. (1994) A structural model for the prostate disease marker, human prostate-specific antigen. Protein Sci. 3, 2033-2044.
41. Carvalho, A. L., Sanz, L., Barettino, D., Romero, A., Calvete, J. J. and Romao, M. J. (2002) Crystal structure of a prostate kallikrein isolated from stallion seminal plasma: A homologue of human PSA. J. Mol. Biol. 322, 325-337.
42. Olsson, A. Y., Bjartell, A., Lilja, H. and Lundwall, A. (2005) Expression of prostate-specific antigen (PSA) and human glandular kallikrein 2 (hK2) in ileum and other extraprostatic tissues. Int. J. Cancer 113, 290-297.
43. Petraki, C. D., Papanastasiou, P. A., Karavana, V. N. and Diamandis, E. P. (2006) Cellular distribution of human tissue kallikreins: Immunohistochemical localization. Biol. Chem. 387, 653-663.
44. Shaw, J. L. and Diamandis, E. P. (2007) Distribution of 15 human kallikreins in tissues and biological fluids. Clin. Chem. 53, 1423-1432.
45. Diamandis, E. P. and Yousef, G. M. (2002) Human tissue kallikreins: A family of new cancer biomarkers. Clin. Chem. 48, 1198-1205.
46. Olsson, A. Y. and Lundwall, A. (2002) Organization and evolution of the glandular kallikrein locus in Mus musculus. Biochem. Biophys. Res. Commun. 299, 305-311.
47. Olsson, A. Y., Lilja, H. and Lundwall, A. (2004) Taxon-specific evolution of glandular kallikrein genes and identification of a progenitor of prostate-specific antigen. Genomics 84, 147-156.
48. Elliott, M. B., Irwin, D. M. and Diamandis, E. P. (2006) In silico identification and Bayesian phylogenetic analysis of multiple new mammalian kallikrein gene families. Genomics 88, 591-599.
49. Gauthier, E. R., Chapdelaine, P., Tremblay, R. R. and Dube, J. Y. (1993) Characterization of rhesus monkey prostate specific antigen cDNA. Biochim. Biophys. Acta 1174, 207-210.
50. Olsson, A. Y., Persson, A. M., Valtonen-Andre, C. and Lundwall, A. (2000) Glandular kallikreins of the cotton-top tamarin: Molecular cloning of the gene encoding the tissue kallikrein. DNACell Biol. 19, 721-727.
51. Olsson, A. Y., Valtonen-Andre, C., Lilja, H. and Lundwall, A. (2004) The evolution of the glandular kallikrein locus: Identification of orthologs and pseudogenes in the cotton-top tamarin. Gene 343, 347-355.
52. Gauthier, E. R., Dumas, C., Chapdelaine, P., Tremblay, R. R. and Dube, J. Y. (1994) Characterization of canine pancreas kallikrein cDNA. Biochim. Biophys. Acta 1218, 102-104.
53. Lazure, C., Leduc, R., Seidah, N. G., Chretien, M., Dube, J. Y., Chapdelaine, P., Frenette, G., Paquin, R. and Tremblay, R. R. (1984) The major androgen-dependent protease in dog prostate belongs to the kallikrein family: Confirmation by partial amino acid sequencing. FEBS Lett. 175, 1-7.
54. Lundwall, A., Clauss, A. and Olsson, A. Y. (2006) Evolution of kallikrein-related peptidases in mammals and identification of a genetic locus encoding potential regulatory inhibitors. Biol. Chem. 387, 243-249.
55. Moreau, M. E., Garbacki, N., Molinaro, G., Brown, N. J., Marceau, F. and Adam, A. (2005) The kallikrein-kinin system: Current and future pharmacological targets. J. Pharmacol. Sci. 99, 6-38.
56. Madeddu, P., Emanueli, C. and El-Dahr, S. (2007) Mechanisms of disease: The tissue kallikrein-kinin system in hypertension and vascular remodeling. Nature Clin. Pract. 3, 208-221.
57. Leeb-Lundberg, L. M., Marceau, F., Muller-Esterl, W., Pettibone, D. J. and Zuraw, B. L. (2005) International union of pharmacology. XLV. Classification of the kinin receptor family: From molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 57, 27-77.
58. Marceau, F., Hess, J. F. and Bachvarov, D. R. (1998) The B1 receptors for kinins. Pharmacol. Rev. 50, 357-386.
59. Kita, M., Nakamura, Y., Okumura, Y., Ohdachi, S. D., Oba, Y., Yoshikuni, M., Kido, H. and Uemura, D. (2004) Blarina toxin, a mammalian lethal venom from the short-tailed shrew Blarina brevicauda: Isolation and characterization. Proc. Natl. Acad. Sci. USA 101, 7542-7547.
60. Berger, E. A. and Shooter, E. M. (1977) Evidence for pro-beta-nerve growth factor, a biosynthetic precursor to beta-nerve growth factor. Proc. Natl. Acad. Sci. USA 74, 3647-3651.
61. Simmer, J. P., Fukae, M., Tanabe, T., Yamakoshi, Y., Uchida, T., Xue, J., Margolis, H. C., Shimizu, M., DeHart, B. C., Hu, C. C. and Bartlett, J. D. (1998) Purification, characterization, and cloning of enamel matrix serine proteinase 1. J. Dent. Res. 77, 377-386.
62. Tamura, H., Ishikawa, Y., Hino, N., Maeda, M., Yoshida, S., Kaku, S. and Shiosaka, S. (2006) Neuropsin is essential for early processes of memory acquisition and Schaffer collateral long-term potentiation in adult mouse hippocampus in vivo. J. Physiol. 570, 541-551.
63. Terayama, R., Bando, Y., Murakami, K., Kato, K., Kishibe, M. and Yoshida, S. (2007) Neuropsin promotes oligodendrocyte death, demyelination and axonal degeneration after spinal cord injury. Neuroscience 148, 175-187.
64. Iwata, A., Maruyama, M., Akagi, T., Hashikawa, T., Kanazawa, I., Tsuji, S. and Nukina, N. (2003) Alpha-synuclein degradation by serine protease neurosin: Implication for pathogenesis of synucleinopathies. Hum. Mol. Genet. 12, 2625-2635.
65. Little, S. P., Dixon, E. P., Norris, F., Buckley, W., Becker, G. W., Johnson, M., Dobbins, J. R., Wyrick, T., Miller, J. R., MacKellar, W., Hepburn, D., Corvalan, J., McClure, D., Liu, X., Stephenson, D., Clemens, J. and Johnstone, E. M. (1997) Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain. J. Biol. Chem. 272, 25135-25142.
66. Terayama, R., Bando, Y., Jiang, Y. P., Mitrovic, B. and Yoshida, S. (2005) Differential expression of protease M/neurosin in oligodendrocytes and their progenitors in an animal model of multiple sclerosis. Neurosci. Lett. 382, 82-87.
67. Blaber, S. I., Ciric, B., Christophi, G. P., Bernett, M. J., Blaber, M., Rodriguez, M. and Scarisbrick, I. A. (2004) Targeting kallikrein 6 proteolysis attenuates CNS inflammatory disease. FASEB J. 18, 920-922.
68. Scarisbrick, I. A., Blaber, S. I., Lucchinetti, C. F., Genain, C. P., Blaber, M. and Rodriguez, M. (2002) Activity of a newly identified serine protease in CNS demyelination. Brain 125, 1283-1296.
69. Candi, E., Schmidt, R. and Melino, G. (2005) The cornified envelope: A model of cell death in the skin. Nat. Rev. Mol. Cell. Biol. 6, 328-340.
70. Egelrud, T. (2000) Desquamation in the stratum corneum. Acta Derm. Venereol. Suppl. (Stockh). 208, 44-45.
71. Egelrud, T., Hofer, P. A. and Lundström, A. (1988) Proteolytic degradation of desmosomes in plantar stratum corneum leads to cell dissociation in vitro. Acta Derm. Venereol. 68, 93-97.
72. Lundström, A. and Egelrud, T. (1988) Cell shedding from human plantar skin in vitro: Evidence of its dependence on endogenous proteolysis. J. Invest. Dermatol. 91, 340-343.
73. Lundström, A. and Egelrud, T. (1990) Cell shedding from human plantar skin in vitro: Evidence that two different types of protein structures are degraded by a chymotrypsin-like enzyme. Arch. Dermatol. Res. 282, 234-237.
74. Lundström, A. and Egelrud, T. (1990) Evidence that cell shedding from plantar stratum corneum in vitro involves endogenous proteolysis of the desmosomal protein desmoglein I. J. Invest. Dermatol. 94, 216-220.
75. Suzuki, Y., Koyama, J., Moro, O., Horii, I., Kikuchi, K., Tanida, M. and Tagami, H. (1996) The role of two endogenous proteases of the stratum corneum in degradation of desmoglein-1 and their reduced activity in the skin of ichthyotic patients. Br. J. Dermatol. 134, 460-464.
76. Suzuki, Y., Nomura, J., Koyama, J. and Horii, I. (1994) The role of proteases in stratum corneum: Involvement in stratum corneum desquamation. Arch. Dermatol. Res. 286, 249-253.
77. Wachter, A. M. and Lezdey, J. (1992) Treatment of atopic dermatitis with alpha 1-proteinase inhibitor. Ann. Allergy. 69, 407-414.
78. Hansson, L., Strömqvist, M., Bäckman, A., Wallbrandt, P., Carlstein, A. and Egelrud, T. (1994) Cloning, expression, and characterization of stratum corneum chymotryptic enzyme. A skin-specific human serine proteinase. J. Biol. Chem. 269, 19420-19426.
79. Ekholm, E. and Egelrud, T. (1998) The expression of stratum corneum chymotryptic enzyme in human anagen hair follicles: Further evidence for its involvement in desquamation-like processes. Br. J. Dermatol. 139, 585-590.
80. Ekholm, E., Sondell, B., Strandén, P., Brattsand, M. and Egelrud, T. (1998) Expression of stratum corneum chymotryptic enzyme in human sebaceous follicles. Acta Derm. Venereol. 78, 343-347.
81. Ekholm, I. E., Brattsand, M. and Egelrud, T. (2000) Stratum corneum tryptic enzyme in normal epidermis: A missing link in the desquamation process? J. Invest. Dermatol. 114, 56-63.
82. Sondell, B., Thornell, L. E., Stigbrand, T. and Egelrud, T. (1994) Immunolocalization of stratum corneum chymotryptic enzyme in human skin and oral epithelium with monoclonal antibodies: Evidence of a proteinase specifically expressed in keratinizing squamous epithelia. J. Histochem. Cytochem. 42, 459-465.
83. Stefansson, K., Brattsand, M., Roosterman, D., Kempkes, C., Bocheva, G., Steinhoff, M. and Egelrud, T. (2008) Activation of proteinase-activated receptor-2 by human kallikrein-related peptidases. J. Invest. Dermatol. 128, 18-25.
84. Komatsu, N., Takata, M., Otsuki, N., Toyama, T., Ohka, R., Takehara, K. and Saijoh, K. (2003) Expression and localization of tissue kallikrein mRNAs in human epidermis and appendages. J. Invest. Dermatol. 121, 542-549.
85. Komatsu, N., Saijoh, K., Toyama, T., Ohka, R., Otsuki, N., Hussack, G., Takehara, K. and Diamandis, E. P. (2005) Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases. Br. J. Dermatol. 153, 274-281.
86. Hansson, L., Bäckman, A., Ny, A., Edlund, M., Ekholm, E., Ekstrand Hammarström, B., Törnell, J., Wallbrandt, P., Wennbo, H. and Egelrud, T. (2002) Epidermal overexpression of stratum corneum chymotryptic enzyme in mice: A model for chronic itchy dermatitis. J. Invest. Dermatol. 118, 444-449.
87. Kirihara, T., Matsumoto-Miyai, K., Nakamura, Y., Sadayama, T., Yoshida, S. and Shiosaka, S. (2003) Prolonged recovery of ultraviolet B-irradiated skin in neuropsin (KLK8)-deficient mice. Br. J. Dermatol. 149, 700-706.
88. Sondell, B., Thornell, L. E. and Egelrud, T. (1995) Evidence that stratum corneum chymotryptic enzyme is transported to the stratum corneum extracellular space via lamellar bodies. J. Invest. Dermatol. 104, 819-823.
89. Caubet, C., Jonca, N., Brattsand, M., Guerrin, M., Bernard, D., Schmidt, R., Egelrud, T., Simon, M. and Serre, G. (2004) Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J. Invest. Dermatol. 122, 1235-1244.
90. Borgoño, C. A., Michael, I. P., Komatsu, N., Jayakumar, A., Kapadia, R., Clayman, G. L., Sotiropoulou, G. and Diamandis, E. P. (2007) A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. J. Biol. Chem. 282, 3640-3652.
91. Kuwae, K., Matsumoto-Miyai, K., Yoshida, S., Sadayama, T., Yoshikawa, K., Hosokawa, K. and Shiosaka, S. (2002) Epidermal expression of serine protease, neuropsin (KLK8) in normal and pathological skin samples. Mol. Pathol. 55, 235-241.
92. Déry, O., Corvera, C. U., Steinhoff, M. and Bunnett, N. W. (1998) Proteinase-activated receptors: Novel mechanisms of signaling by serine proteases. Am. J. Physiol. 274, C1429-1452.
93. Steinhoff, M., Corvera, C. U., Thoma, M. S., Kong, W., McAlpine, B. E., Caughey, G. H., Ansel, J. C. and Bunnett, N. W. (1999) Proteinase-activated receptor-2 in human skin: Tissue distribution and activation of keratinocytes by mast cell tryptase. Exp. Dermatol. 8, 282-294.
94. Oikonomopoulou, K., Hansen, K. K., Saifeddine, M., Vergnolle, N., Tea, I., Blaber, M., Blaber, S. I., Scarisbrick, I., Diamandis, E. P. and Hollenberg, M. D. (2006) Kallikrein-mediated cell signalling: Targeting proteinase-activated receptors (PARs). Biol. Chem. 387, 817-824.
95. Steinhoff, M., Neisius, U., Ikoma, A., Fartasch, M., Heyer, G., Skov, P. S., Luger, T. A. and Schmelz, M. (2003) Proteinase-activated receptor-2 mediates itch: A novel pathway for pruritus in human skin. J. Neurosci. 23, 6176-6180.
96. Materazzi, S., Pellerito, S., Di Serio, C., Paglierani, M., Naldini, A., Ardinghi, C., Carraro, F., Geppetti, P., Cirino, G., Santucci, M., Tarantini, F. and Massi, D. (2007) Analysis of protease-activated receptor-1 and -2 in human scar formation. J. Pathol. 212, 440-449.
97. Paine, C., Sharlow, E., Liebel, F., Eisinger, M., Shapiro, S. and Seiberg, M. (2001) An alternative approach to depigmentation by soybean extracts via inhibition of the PAR-2 pathway. J. Invest. Dermatol. 116, 587-595.
98. Hachem, J. P., Houben, E., Crumrine, D., Man, M. Q., Schurer, N., Roelandt, T., Choi, E. H., Uchida, Y., Brown, B. E., Feingold, K. R. and Elias, P. M. (2006) Serine protease signaling of epidermal permeability barrier homeostasis. J. Invest. Dermatol. 126, 2074-2086.
99. Yamasaki, K., Di Nardo, A., Bardan, A., Murakami, M., Ohtake, T., Coda, A., Dorschner, R. A., Bonnart, C., Descargues, P., Hovnanian, A., Morhenn, V. B. and Gallo, R. L. (2007) Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat. Med. 13, 975-980.
100. Yamasaki, K., Schauber, J., Coda, A., Lin, H., Dorschner, R. A., Schechter, N. M., Bonnart, C., Descargues, P., Hovnanian, A. and Gallo, R. L. (2006) Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J. 20, 2068-2080.
101. Ohman, H. and Vahlquist, A. (1994) In vivo studies concerning a pH gradient in human stratum corneum and upper epidermis. Acta Derm. Venereol. 74, 375-379.
102. Yoon, H., Laxmikanthan, G., Lee, J., Blaber, S. I., Rodriguez, A., Kogot, J. M., Scarisbrick, I. A. and Blaber, M. (2007) Activation profiles and regulatory cascades of the human kallikrein-related peptidases. J. Biol. Chem. 282, 31852-31864.
103. Emami, N. and Diamandis, E. P. (2008) Human kallikrein-related peptidase 14 (KLK14) is a new activator component of the KLK proteolytic cascade: Possible function in seminal plasma and skin. J. Biol. Chem. 283, 3031-3041.
104. Sato, J., Denda, M., Nakanishi, J. and Koyama, J. (1998) Dry condition affects desquamation of stratum corneum in vivo. J. Dermatol. Sci. 18, 163-169.
105. Watkinson, A., Harding, C., Moore, A. and Coan, P. (2001) Water modulation of stratum corneum chymotryptic enzyme activity and desquamation. Arch. Dermatol. Res. 293, 470-476.
106. Egelrud, T. (1993) Purification and preliminary characterization of stratum corneum chymotryptic enzyme: A proteinase that may be involved in desquamation. J. Invest. Dermatol. 101, 200-204.
107. Chavanas, S., Bodemer, C., Rochat, A., Hamel-Teillac, D., Ali, M., Irvine, A. D., Bonafé, J. L., Wilkinson, J., Taïeb, A., Barrandon, Y., Harper, J. I., de Prost, Y. and Hovnanian, A. (2000) Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat. Genet. 25, 141-142.
108. Mägert, H. J., Ständker, L., Kreutzmann, P., Zucht, H. D., Reinecke, M., Sommerhoff, C. P., Fritz, H. and Forssmann, W. G. (1999) LEKTI, a novel 15-domain type of human serine proteinase inhibitor. J. Biol. Chem. 274, 21499-21502.
109. Deraison, C., Bonnart, C., Lopez, F., Besson, C., Robinson, R., Jayakumar, A., Wagberg, F., Brattsand, M., Hachem, J. P., Leonardsson, G. and Hovnanian, A. (2007) LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction. Mol. Biol. Cell 18, 3607-3619.
110. Egelrud, T., Brattsand, M., Kreutzmann, P., Walden, M., Vitzithum, K., Marx, U. C., Forssmann, W. G. and Mägert, H. J. (2005) hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6. Br. J. Dermatol. 153, 1200-1203.
111. Schechter, N. M., Choi, E. J., Wang, Z. M., Hanakawa, Y., Stanley, J. R., Kang, Y., Clayman, G. L. and Jayakumar, A. (2005) Inhibition of human kallikreins 5 and 7 by the serine protease inhibitor lympho-epithelial Kazal-type inhibitor (LEKTI). Biol. Chem. 386, 1173-1184.
112. Franzke, C. W., Baici, A., Bartels, J., Christophers, E. and Wiedow, O. (1996) Antileukoprotease inhibits stratum corneum chymotryptic enzyme. Evidence for a regulative function in desquamation. J. Biol. Chem. 271, 21886-21890.
113. Nonomura, K., Yamanishi, K., Yasuno, H., Nara, K. and Hirose, S. (1994) Up-regulation of elafin/SKALP gene expression in psoriatic epidermis. J. Invest. Dermatol. 103, 88-91.
114. Wiedow, O., Harder, J., Bartels, J., Streit, V. and Christophers, E. (1998) Antileukoprotease in human skin: An antibiotic peptide constitutively produced by keratinocytes. Biochem. Biophys. Res. Commun. 248, 904-909.
115. Shapiro, L. J., Weiss, R., Buxman, M. M., Vidgoff, J., Dimond, R. L., Roller, J. A. and Wells, R. S. (1978) Enzymatic basis of typical X-linked icthyosis. Lancet 2, 756-757.
116. Sato, J., Denda, M., Nakanishi, J., Nomura, J. and Koyama, J. (1998) Cholesterol sulfate inhibits proteases that are involved in desquamation of stratum corneum. J. Invest. Dermatol. 111, 189-193.
117. Lilja, H., Abrahamsson, P. A. and Lundwall, A. (1989) Semenogelin, the predominant protein in human semen. Primary structure and identification of closely related proteins in the male accessory sex glands and on the spermatozoa. J. Biol. Chem. 264, 1894-1900.
118. Lilja, H. and Lundwall, A. (1992) Molecular cloning of epididymal and seminal vesicular transcripts encoding a semenogelin-related protein. Proc. Natl. Acad. Sci. USA 89, 4559-4563.
119. Lundwall, A., Bjartell, A., Olsson, A. Y. and Malm, J. (2002) Semenogelin I and II, the predominant human seminal plasma proteins, are also expressed in non-genital tissues. Mol. Hum. Reprod. 8, 805-810.
120. Malm, J., Hellman, J., Magnusson, H., Laurell, C. B. and Lilja, H. (1996) Isolation and characterization of the major gel proteins in human semen, semenogelin I and semenogelin II. Eur. J. Biochem. 238, 48-53.
121. Lilja, H. (1988) Structure and function of prostatic- and seminal vesicle-secreted proteins involved in the gelation and liquefaction of human semen. Scand. J. Clin. Lab. Invest. 191, 13-20.
122. Lilja, H. and Laurell, C. B. (1985) The predominant protein in human seminal coagulate. Scand. J. Clin. Lab. Invest. 45, 635-641.
123. Jonsson, M., Linse, S., Frohm, B., Lundwall, A. and Malm, J. (2005) Semenogelins I and II bind zinc and regulate the activity of prostate-specific antigen. Biochem. J. 387, 447-453.
124. Koistinen, H., Soini, T., Leinonen, J., Hyden-Granskog, C., Salo, J., Halttunen, M., Stenman, U. H., Seppala, M. and Koistinen, R. (2002) Monoclonal antibodies, immunofluorometric assay, and detection of human semenogelin in male reproductive tract: No association with in vitro fertilizing capacity of sperm. Biol. Reprod. 66, 624-628.
125. Lilja, H. and Laurell, C. B. (1984) Liquefaction of coagulated human semen. Scand. J. Clin. Lab. Invest. 44, 447-452.
126. McGee, R. S. and Herr, J. C. (1987) Human seminal vesicle-specific antigen during semen liquefaction. Biol. Reprod. 37, 431-439.
127. Lilja, H. (1985) A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J. Clin. Invest. 76, 1899-1903.
128. McGee, R. S. and Herr, J. C. (1988) Human seminal vesicle-specific antigen is a substrate for prostate-specific antigen (or P-30). Biol. Reprod. 39, 499-510.
129. Laurell, M., Christensson, A., Abrahamsson, P. A., Stenflo, J. and Lilja, H. (1992) Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system. J. Clin. Invest. 89, 1094-1101.
130. Christensson, A. and Lilja, H. (1994) Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen. Eur. J. Biochem. 220, 45-53.
131. Lovgren, J., Valtonen-Andre, C., Marsal, K., Lilja, H. and Lundwall, A. (1999) Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids. J. Androl. 20, 348-355.
132. Kumar, A., Mikolajczyk, S. D., Goel, A. S., Millar, L. S. and Saedi, M. S. (1997) Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2. Cancer Res. 57, 3111-3114.
133. Lovgren, J., Rajakoski, K., Karp, M., Lundwall, A. and Lilja, H. (1997) Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2. Biochem. Biophys. Res. Commun. 238, 549-555.
134. Takayama, T. K., Fujikawa, K. and Davie, E. W. (1997) Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein. J. Biol. Chem. 272, 21582-21588.
135. Michael, I. P., Pampalakis, G., Mikolajczyk, S. D., Malm, J., Sotiropoulou, G. and Diamandis, E. P. (2006) Human tissue kallikrein 5 is a member of a proteolytic cascade pathway involved in seminal clot liquefaction and potentially in prostate cancer progression. J. Biol. Chem. 281, 12743-12750.
136. Takayama, T. K., Carter, C. A. and Deng, T. (2001) Activation of prostate-specific antigen precursor (pro-PSA) by prostin, a novel human prostatic serine protease identified by degenerate PCR. Biochemistry 40, 1679-1687.
137. Takayama, T. K., McMullen, B. A., Nelson, P. S., Matsumura, M. and Fujikawa, K. (2001) Characterization of hK4 (prostase), a prostate-specific serine protease: Activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase. Biochemistry 40, 15341-15348.
138. Denmeade, S. R., Sokoll, L. J., Chan, D. W., Khan, S. R. and Isaacs, J. T. (2001) Concentration of enzymatically active prostate-specific antigen (PSA) in the extracellular fluid of primary human prostate cancers and human prostate cancer xenograft models. Prostate 48, 1-6.
139. Debela, M., Goettig, P., Magdolen, V., Huber, R., Schechter, N. M. and Bode, W. (2007) Structural basis of the zinc inhibition of human tissue kallikrein 5. J. Mol. Biol. 373, 1017-1031.
140. Debela, M., Magdolen, V., Grimminger, V., Sommerhoff, C., Messerschmidt, A., Huber, R., Friedrich, R., Bode, W. and Goettig, P. (2006) Crystal structures of human tissue kallikrein 4: Activity modulation by a specific zinc binding site. J. Mol. Biol. 362, 1094-1107.
141. Kuriyama, M., Wang, M. C., Lee, C. I., Papsidero, L. D., Killian, C. S., Inaji, H., Slack, N. H., Nishiura, T., Murphy, G. P. and Chu, T. M. (1981) Use of human prostate-specific antigen in monitoring prostate cancer. Cancer Res. 41, 3874-3876.
142. Wang, M. C., Papsidero, L. D., Kuriyama, M., Valenzuela, L. A., Murphy, G. P. and Chu, T. M. (1981) Prostate antigen: A new potential marker for prostatic cancer. Prostate 2, 89-96.
143. Wang, M. C., Valenzuela, L. A., Murphy, G. P. and Chu, T. M. (1979) Purification of a human prostate specific antigen. Investig. Urol. 17, 159-163.
144. Christensson, A., Laurell, C. B. and Lilja, H. (1990) Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur. J. Biochem. 194, 755-763.
145. Lilja, H., Christensson, A., Dahlen, U., Matikainen, M. T., Nilsson, O., Pettersson, K. and Lovgren, T. (1991) Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. Clin. Chem. 37, 1618-1625.
146. Christensson, A., Bjork, T., Nilsson, O., Dahlen, U., Matikainen, M. T., Cockett, A. T., Abrahamsson, P. A. and Lilja, H. (1993) Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer. J. Urol. 150, 100-105.
147. Stenman, U. H., Leinonen, J., Alfthan, H., Rannikko, S., Tuhkanen, K. and Alfthan, O. (1991) A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer. Cancer Res. 51, 222-226.
148. Carter, H. B., Pearson, J. D., Metter, E. J., Brant, L. J., Chan, D. W., Andres, R., Fozard, J. L. and Walsh, P. C. (1992) Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 267, 2215-2220.
149. Babaian, R. J., Fritsche, H. A. and Evans, R. B. (1990) Prostate-specific antigen and prostate gland volume: Correlation and clinical application. J. Clin. Lab. Anal. 4, 135-137.
150. Veneziano, S., Pavlica, P., Querze, R., Nanni, G., Lalanne, M. G. and Vecchi, F. (1990) Correlation between prostate-specific antigen and prostate volume, evaluated by transrectal ultrasonography: Usefulness in diagnosis of prostate cancer. Eur. Urol. 18, 112-116.
151. Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Coplen, D. E., Yuan, J. J., Petros, J. A. and Andriole, G. L. (1991) Measurement of
152. Lilja, H., Ulmert, D., Bjork, T., Becker, C., Serio, A. M., Nilsson, J. A., Abrahamsson, P. A., Vickers, A. J. and Berglund, G. (2007) Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years. J. Clin. Oncol. 25, 431-436.
153. Becker, C., Piironen, T., Pettersson, K., Bjork, T., Wojno, K. J., Oesterling, J. E. and Lilja, H. (2000) Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum. J. Urol. 163, 311-316.
154. Partin, A. W., Catalona, W. J., Finlay, J. A., Darte, C., Tindall, D. J., Young, C. Y., Klee, G. G., Chan, D. W., Rittenhouse, H. G., Wolfert, R. L. and Woodrum, D. L. (1999) Use of human glandular kallikrein 2 for the detection of prostate cancer: Preliminary analysis. Urology 54, 839-845.
155. Saedi, M. S., Hill, T. M., Kuus-Reichel, K., Kumar, A., Payne, J., Mikolajczyk, S. D., Wolfert, R. L. and Rittenhouse, H. G. (1998) The precursor form of the human kallikrein 2, a kallikrein homologous to prostate-specific antigen, is present in human sera and is increased in prostate cancer and benign prostatic hyperplasia. Clin. Chem. 44, 2115-2119.
156. Haese, A., Becker, C., Noldus, J., Graefen, M., Huland, E., Huland, H. and Lilja, H. (2000) Humanglandular kallikrein 2: A potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer. J. Urol. 163, 1491-1497.
157. Recker, F., Kwiatkowski, M. K., Piironen, T., Pettersson, K., Huber, A., Lummen, G. and Tscholl, R. (2000) Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen. Urology 55, 481-485.
158. Nelson, P. S., Gan, L., Ferguson, C., Moss, P., Gelinas, R., Hood, L. and Wang, K. (1999) Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression. Proc. Natl. Acad. Sci. USA 96, 3114-3119.
159. Obiezu, C. V., Soosaipillai, A., Jung, K., Stephan, C., Scorilas, A., Howarth, D. H. and Diamandis, E. P. (2002) Detection of human kallikrein 4 in healthy and cancerous prostatic tissues by immunofluorometry and immunohistochemistry. Clin. Chem. 48, 1232-1240.
160. Xi, Z., Klokk, T. I., Korkmaz, K., Kurys, P., Elbi, C., Risberg, B., Danielsen, H., Loda, M. and Saatcioglu, F. (2004) Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer. Cancer Res. 64, 2365-2370.
161. Kurlender, L., Yousef, G. M., Memari, N., Robb, J. D., Michael, I. P., Borgono, C., Katsaros, D., Stephan, C., Jung, K. and Diamandis, E. P. (2004) Differential expression of a human kallikrein 5 (KLK5) splice variant in ovarian and prostate cancer. Tumour Biol. 25, 149-156.
162. Yousef, G. M., Scorilas, A., Chang, A., Rendl, L., Diamandis, M., Jung, K. and Diamandis, E. P. (2002) Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues. Prostate 51, 126-132.
163. Scorilas, A. and Gregorakis, A. K. (2006) mRNA expression analysis of human kallikrein 11 (KLK11) may be useful in the discrimination of benign prostatic hyperplasia from prostate cancer after needle prostate biopsy. Biol. Chem. 387, 789-793.
164. Stavropoulou, P., Gregorakis, A. K., Plebani, M. and Scorilas, A. (2005) Expression analysis and prognostic significance of human kallikrein 11 in prostate cancer. Clin. Chim. Acta 357, 190-195.
165. Borgono, C. A., Michael, I. P., Shaw, J. L., Luo, L. Y., Ghosh, M. C., Soosaipillai, A., Grass, L., Katsaros, D. and Diamandis, E. P. (2007) Expression and functional characterization of the cancer-related serine protease, human tissue kallikrein 14. J. Biol. Chem. 282, 2405-2422.
166. Yousef, G. M., Stephan, C., Scorilas, A., Ellatif, M. A., Jung, K., Kristiansen, G., Jung, M., Polymeris, M. E. and Diamandis, E. P. (2003) Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues. Prostate 56, 287-292.
167. Yousef, G. M., Scorilas, A., Jung, K., Ashworth, L. K. and Diamandis, E. P. (2001) Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer. J. Biol. Chem. 276, 53-61.
168. Paliouras, M., Borgono, C. and Diamandis, E. P. (2007) Human tissue kallikreins: The cancer biomarker family. Cancer Lett. 249, 61-79.
169. Yu, H., Giai, M., Diamandis, E. P., Katsaros, D., Sutherland, D. J., Levesque, M. A., Roagna, R., Ponzone, R. and Sismondi, P. (1995) Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res. 55, 2104-2110.
170. Giai, M., Yu, H., Roagna, R., Ponzone, R., Katsaros, D., Levesque, M. A. and Diamandis, E. P. (1995) Prostate-specific antigen in serum of women with breast cancer. Br. J. Cancer 72, 728-731.
171. Laxmikanthan, G., Blaber, S. I., Bernett, M. J., Scarisbrick, I. A., Juliano, M. A. and Blaber, M. (2005) 1.70 A X-ray structure of human apo kallikrein 1: Structural changes upon peptide inhibitor/substrate binding. Proteins 58, 802-814.